Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan

被引：0
|
作者：
Galie, N. [1 ]
Delcroix, M. [2 ]
Ghofrani, H. -A. [3 ]
Jansa, P. [4 ]
Minai, O. A. [5 ]
Perchenet, L. [6 ]
Rubin, L. J. [7 ]
Sastry, B. K. S. [8 ]
Torbicki, A. [9 ]
Simonneau, G. [10 ]
机构：
[1] Univ Hosp Policlin S Orsola Malpighi, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[2] Univ Hosp UZ Leuven, Dept Pneumol, Leuven, Belgium
[3] Univ Giessen & Marburg Lung Ctr, Univ Hosp Giessen & Marburg, Giessen, Germany
[4] Charles Univ Prague, Clin Dept Cardiol & Angiol, Prague, Czech Republic
[5] Cleveland Clin Fdn, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44195 USA
[6] Actel Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Calif San Diego, Div Pulm & Crit Care Med, San Diego, CA 92103 USA
[8] CARE Hosp, Dept Cardiol, Hyderabad, Andhra Pradesh, India
[9] ECZ Otwock, Dept Pulm Circulat & Thromboembol Dis, Ctr Postgrad Med Educ, Otwock, Poland
[10] Hop Bicetre, Serv Pneumol, Le Kremlin Bicetre, France
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
65
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
    Sitbon, Olivier
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B. K. S.
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] EFFECT OF MACITENTAN ON HAEMODYNAMICS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE LONG-TERM, RANDOMISED, PLACEBO-CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Torbicki, A.
    Galie, N.
    Rubin, L. J.
    Perchenet, L.
    Simonneau, G.
    [J]. THORAX, 2013, 68 : A26 - A26
  • [3] Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial
    Torbicki, A.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B. K. S.
    Sitbon, O.
    Souza, R.
    Rubin, L. J.
    Simonneau, G.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 186 - 186
  • [4] SAFETY AND EFFICACY OF MACITENTAN IN ELDERLY PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM SERAPHIN
    Langleben, David
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Ardeschir
    Jansa, Pavel
    Mehta, Sanjay
    Pulido, Tomas
    Souza, Rogerio
    Simonneau, Gerald
    Sastry, B. K. S.
    Torbicki, Adam
    Martin, Nicolas
    Perchenet, Loic
    Sitbon, Olivier
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2090 - 2090
  • [5] Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN)
    Ghofrani, Hossein-Ardeschir
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Mittelholzer, Camilla
    Pulido, Tomas
    Sastry, B. K. S.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] REDUCTION OF PULMONARY ARTERIAL HYPERTENSION (PAH)-RELATED HOSPITALIZATIONS WITH MACITENTAN IN THE RANDOMIZED CONTROLLED TRIAL SERAPHIN
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H. A.
    Hunsche, E.
    Jansa, P.
    Le Brun, F. O.
    Mehta, S.
    Mittelholzer, C.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Rubin, L. J.
    Simonneau, G.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A231 - A231
  • [7] The Effect Of Macitentan On Long-Term Outcomes In Patients With Pulmonary Arterial Hypertension By Who Functional Class: Data From The Randomized Controlled Seraphin Study
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H. A.
    Jansa, P.
    Le Brun, F. O.
    Mehta, S.
    Perchenet, L.
    Pulido, T.
    Sastry, B.
    Sitbon, O.
    Souza, R.
    Torbicki, A.
    Rubin, L. J.
    Simonneau, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] EFFECT OF MACITENTAN ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM THE SERAPHIN RANDOMISED CONTROLLED TRIAL
    Youssef, P.
    Galie, N.
    Perchenet, L.
    Rubin, L.
    Simonneau, G.
    Mehta, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 31 - 31
  • [9] Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy
    Simonneau, Gerald
    Channick, Richard
    Delcroix, Marion
    Galie, Nazzareno
    Ghofrani, Hossein
    Jansa, Pavel
    Le Brun, Franck-Olivier
    Mehta, Sanjay
    Perchenet, Loic
    Pulido, Tomas
    Sastry, B.
    Sitbon, Olivier
    Souza, Rogerio
    Torbicki, Adam
    Rubin, Lewis
    [J]. CHEST, 2013, 144 (04)
  • [10] EFFECT OF MACITENTAN ON PULMONARY ARTERIAL HYPERTENSION-RELATED HOSPITALISATIONS: RESULTS FROM THE RANDOMISED CONTROLLED SERAPHIN TRIAL
    Coghlan, G.
    Channick, R. N.
    Rubin, L. J.
    Galie, N.
    Perchenet, L.
    Simonneau, G.
    [J]. THORAX, 2013, 68 : A143 - A143
12345